Rani Therapeutics Holdings (RANI) Return on Sales (2020 - 2026)
Rani Therapeutics Holdings' (RANI) quarterly Return on Sales came in at 0.06% in Q1 2026, up 68.0% year-on-year from 0.04% in Q1 2025, and down 2.66% quarter-over-quarter from 0.06% in Q4 2025.
Rani Therapeutics Holdings (RANI) Return on Sales (2020 - 2026) Analysis & Trends
Rani Therapeutics Holdings' Return on Sales history runs 6 years deep, the most recent figure standing at 0.06% for Q1 2026.
- On a quarterly basis, Return on Sales rose 68.0% year-over-year to 0.06% in Q1 2026; TTM through Mar 2026 was 0.13%, a 37.0% increase from a year earlier, with the FY2025 full-year figure at 0.71%, down 16.0% from the prior year.
- Return on Sales declined to 0.06% in Q1 2026 per RANI's latest filing, from 0.06% in the prior quarter.
- Across five years, Return on Sales topped out at 0.06% in Q4 2025 and bottomed at 0.74% in Q1 2025.
- The 4-year median for Return on Sales is 0.37% (2022), against an average of 0.33%.
- Across the five-year window, Return on Sales slumped 34 bps in 2022 and surged 68 bps in 2026, its largest moves.
- Year by year, Return on Sales stood at 0.37% in 2022, then jumped by 58 bps to 0.15% in 2024, then soared by 61 bps to 0.06% in 2025, then fell by 3 bps to 0.06% in 2026.
- Per Business Quant, the three latest RANI Return on Sales figures stand at 0.06% (Q1 2026), 0.06% (Q4 2025), and 0.43% (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 0.00% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 0.00% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 0.00% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 0.00% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Rani Therapeutics Holdings | 160.20 Mn | 167.33 Mn | - | -0.06% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.06% |
| Dec 31, 2025 | -0.06% |
| Sep 30, 2025 | -0.43% |
| Jun 30, 2025 | -0.48% |
| Mar 31, 2025 | -0.74% |
| Dec 31, 2024 | -0.15% |
| Jun 30, 2022 | -0.37% |
| Dec 31, 2021 | -0.20% |
| Sep 30, 2021 | -0.16% |
| Jun 30, 2021 | -0.03% |
| Mar 31, 2021 | -0.07% |
| Dec 31, 2020 | -0.27% |
| Sep 30, 2020 | -0.27% |
| Jun 30, 2020 | -0.45% |